XML 53 R42.htm IDEA: XBRL DOCUMENT v3.25.3

Commitments (Details) $ in Millions	1 Months Ended	3 Months Ended			9 Months Ended
	Oct. 31, 2023 USD ($) item	Sep. 30, 2025 USD ($)	Mar. 31, 2025 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)
License agreement
Commitments
Upfront license fee paid	$ 15.0
Maximum fee payable	305.0
Maximum fee payable, upon achievement of development milestones	20.0
Maximum fee payable, upon achievement of regulatory milestones	70.0
Maximum, upon achievement of commercial milestones	$ 215.0
Maximum number of indications under regulatory approval and commercial sales milestones | item	3
Achievement of clinical milestones			$ 2.2
Aggregate milestone payments		$ 0.0	$ 2.0		$ 0.0	$ 0.0
Research services agreement
Commitments
Maximum fee payable, upon achievement of regulatory milestones	$ 5.9
Maximum, upon achievement of commercial milestones	7.0
Achievement of clinical milestones	$ 2.9
Aggregate milestone payments		$ 0.0		$ 0.0	$ 0.0	$ 0.0

X

- Definition

The amount of cash outflow pertaining to aggregate milestone payments.

+ References

No definition available.

+ Details

Name:	atxs_AggregateMilestonePayments
Namespace Prefix:	atxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Number of indications for license fee payable related to related to regulatory approval and commercial sales milestones.

+ References

No definition available.

+ Details

Name:	atxs_LicenseeFeePayableRegulatoryApprovalAndCommercialSalesMilestonesMaximumNumberOfIndications
Namespace Prefix:	atxs_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The maximum amount of fee payable.

+ References

No definition available.

+ Details

Name:	atxs_MaximumFeePayable
Namespace Prefix:	atxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum amount of fee payable upon achievement of clinical milestones.

+ References

No definition available.

+ Details

Name:	atxs_MaximumFeePayableUponAchievementOfClinicalMilestones
Namespace Prefix:	atxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum amount of fee payable upon achievement of development milestones.

+ References

No definition available.

+ Details

Name:	atxs_MaximumFeePayableUponAchievementOfDevelopmentMilestones
Namespace Prefix:	atxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum amount of fee payable upon achievement of regulatory milestones.

+ References

No definition available.

+ Details

Name:	atxs_MaximumFeePayableUponAchievementOfRegulatoryMilestones
Namespace Prefix:	atxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum amount of fee payable upon achievement of commercial milestones.

+ References

No definition available.

+ Details

Name:	atxs_MaximumfeePayableMaximumUponAchievementOfCommercialMilestones
Namespace Prefix:	atxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of upfront license fee paid.

+ References

No definition available.

+ Details

Name:	atxs_PaymentOfUpfrontLicenseFees
Namespace Prefix:	atxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=atxs_ResearchServiceAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: